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The lacrimal gland is responsible for tear synthesis and secre-
tion, and is derived from the epithelia of ocular surface and
generated by branching morphogenesis. The dataset presented
in this article is to support the research results of the effect of
chitosan biomaterials on facilitating the structure formation of
the lacrimal gland by regulating temporospatial dynamics of
morphogen. The embryonic lacrimal gland explants were used
as the standard experimental model for investigating lacrimal
gland branching morphogenesis. Chitosan biomaterials pro-
moted lacrimal gland branching with a dose-dependent effect.
It helped in vivo binding of hepatocyte growth factor (HGF)
related molecules in the epithelial-mesenchymal boundary of
emerging epithelial branches. When mitogen-activated protein
kinase (MAPK) or protein kinase B (Akt/PKB) inhibitors applied,
the chitosan effects reduced. Nonetheless, the ratios of MAPK
and Akt/PKB phosphorylation were still greater in the chitosan
group than the control. The data demonstrated here conﬁrmis an open access article under the CC BY license
/j.biomaterials.2016.10.012
Taipei 100, Taiwan. Fax: þ886 2 23940049.
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structure formation of the lacrimal gland.
& 2016 Published by Elsevier Inc. This is an open access article
under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Biology; Biomaterials
ore speciﬁc sub-
ject areaThe morphogenetic effect of chitosan biomaterials on the lacrimal gland struc-
ture formationype of data Figures and Charts
ow data was
acquiredAn ex vivo culture of the embryonic lacrimal gland explants was used.
The ligands and receptors of HGF-related molecules were tested.ata format Raw and analyzed Data
xperimental
factorsThe lacrimal gland explants were cultured in a chitosan-containing system to
induce branching morphogenesis. The effect of morphogen was tested.xperimental
featuresThe effect of chitosan on branching of the lacrimal gland explants was deter-
mined by imaging and quantitative analyses.ata source location The National Taiwan University, Taipei, Taiwan
ata accessibility Data is available with this articleValue of the data
 The data allow other researchers to investigate the effect of biomaterial using the explants of
embryonic lacrimal glands as an experimental model.
 The data reveals the morphogenetic effects of chitosan in facilitating lacrimal gland structure
formation.
 The chitosan-mediated morphogenetic effects on lacrimal gland explants originated from increas-
ing expression and binding of hepatocyte growth factor (HGF) related molecules.1. Experimental design, materials and methods
1.1. Preparation of the chitosan-containing system
To establish the chitosan-containing system for ex vivo culture of lacrimal gland explants, the
water-soluble form of chitosan was ﬁrstly prepared. A 2 wt.% (w/v) chitosan solution was prepared by
dissolving chitosan (Sigma–Aldrich Chemical Co. St. Louis, MO, USA) in 1 M acetic acid. The chitosan
solution was then mixed with the medium used for lacrimal gland explant culture, neutralized with
sodium hydroxide, added with additives, and prepared in the concentrations ranging from 0.1 to
0.4 mg/ml [1,2]. For comparison, the mock was prepared similarly as that of the chitosan-containing
medium, by adding the same amount of acetic acid and sodium hydroxide without chitosan. It had
been conﬁrmed that the mock and the control media had similar effects without signiﬁcant differ-
ences in ex vivo explant morphogenesis [3]. It is therefore the control medium was used for com-
parison in all explant assays.
Fig. 1. The ex vivo chitosan-containing culture system for the structure formation of the lacrimal glands. (a) The chitosan
system for the ex vivo culture experiments of the lacrimal gland explant. Scale bars: 5 mm. (b) A cartoon illustrates that the
lacrimal gland explant is cultured on a membrane ﬁlter on the top of media. (E: explant; M: membrane; CM: culture media).
(c) The lateral view of the cartoon demonstrates supply of culture medium components for explant culture and morphogenesis.
(Epi: explant epithelia; Mes: explant mesenchyme; Small circles with colors represent distinct components of culture medium;
Arrows: transportation of the components of culture medium).
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In this study, the ICR mice strain was used. Animal protocols were approved by the Animal Care
and Use Committee of the National Taiwan University and were in accordance with the guidelines.
E16.5 lacrimal glands were used for explant culture, and the protocol followed the methods described
previously [4]. The harvested lacrimal gland explants were placed on the 13 mm polycarbonate
membrane ﬁlters (Nuclepore
s
, Whatman, Clifton, NJ, USA). The membrane had numerous tiny pores
for transportation of the constituents of culture medium. The setting kept lacrimal gland explants
cultured in a submerged fashion of culture medium with an air/medium interface (Fig. 1). The
medium was composed of DMEM/F12 supplemented with 50 μg/ml ascorbic acid and 50 μg/ml
transferrin. All explants were cultured at 37 °C in a humidiﬁed 5% CO2/95% air atmosphere. The
cultured lacrimal gland explants were photographed and measured at the indicated time-points as
experimental design. The lacrimal gland branching was quantiﬁed as the fold-change of branch
numbers between the chitosan and control groups. At least three experimental repeats were averaged
for comparison.
Table 1
Primers for RT-PCR and qPCR analyses.
Gene
symbol
Primer sequences Base
pairs
Sequence accession
number
GAPDH F: TGGCATTGCTCTCAATGAC 122 NM_008084.2
R: AGGGTTTCTTACTCCTTGG
HGF F: CTGAGGAATGTCACAGACTTC 276 NM_010427.5
R: CCATGAATTTGACCTCTATGA
c-Met F: GCTACCAGTAAAGTGGATGG 377 NM_008591.2
R: GGCAACAGAGAAGGATATGG
HAI-1 F: GGGCAACAAGAACAACTACC 274 NM_016907.3
R: CACAGTACCCTTTGTCACTG
HAI-2 F: CTCTTCTGTCCTGAGTGTTC 544 NM_011464.2
R: CAGCACTGGGAAACAAAGAC
HGFa F: CATGACCTTGTCTTGATCCG 242 NM_019447.2
R: GTCAGCACCATATACCTCTG
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A modiﬁed ligand and carbohydrate engagement (LACE) assay was designed based on the
methodology previously described [5]. The recombinant proteins of HGF and c-Met that were used as
probes (R&D Systems, MN, USA). After culture in the chitosan and control groups, the lacrimal gland
explants were harvested respectively from both groups, and then washed, permeabilized, and blocked
with 10% BSA overnight at 4 °C. After the pretreatment, the lacrimal gland explants were incubated
with indicated probes (50 nM) for three hours. In the preparation of HGF-c-Met probes, HGF was ﬁrst
incubated with c-Met for ﬁve minutes before use. The anti-human Fc antibody (R&D Systems, MN,
USA) was used to detect the location of applied probes after ﬁxation. Meanwhile, heparan sulfate
proteoglycan (HSPG) was also stained in the lacrimal gland explants with anti-HSPG antibody
(Chemicon, CA, USA), followed by the Cy dye-conjugated secondary antibody for visualization. The
results were recorded by confocal microscopy (SP5; Leica) and analyzed [6].
1.4. Reverse transcription polymerase chain reaction (RT-PCR) and quantitative PCR
The lacrimal gland explants were harvested from each experimental condition. The RNA of
lacrimal gland explants was extracted by RNeasy mini kit (Qiagen), and was prepared for synthesis of
complementary DNA by ReverseAid kit (Thermo Fisher). The speciﬁc primers of HGF related genes
used for RT-PCR and quantitative PCR were listed in Table 1. The experimental procedures of RT-PCR
and quantitative PCR were performed as previously described [7].
1.5. Perturbation of HGF-related signaling pathways
Signaling perturbation of branching lacrimal gland explants was performed as previously descri-
bed [8]. Protein inhibitors, including PD98059 (75 μM; Santa Cruz Biotechnology) and LY294002
(50 μM; Cayman Chemicals, Ann Arbor, MI) were used. The inhibitors were prepared with the con-
centrations suggested by manufacturers and published studies [9]. Meanwhile, the vehicles of protein
inhibitors were applied with similar concentrations for comparison. The lacrimal gland explants were
treated ﬁrst by the inhibitors for 30 min, and then washed and replaced with fresh culture medium
for subsequent culture. The suppressive effects of the signaling inhibitors were conﬁrmed by Western
blotting standardly as described [10].
Fig. 2. The dose-dependent effect of chitosan for the structure formation of the lacrimal glands. (a) The E16.5 lacrimal gland
explants were cultured in the chitosan-containing system for 48 h with indicated concentrations (mg/ml). The scale
bar¼100 μm. (b) The quantitative analyses of branching number were presented as the ratio change of buds.
Fig. 3. Alteration of in vivo binding afﬁnity of HGF-realted molecules by chitosan. The results of LACE assay with (a) c-Met, and
(b) HGF-c-Met complex were demonstrated in the chitosan and control groups. HSPG delineated the basement membrane to
show expression colocalization. (Cont: control group; Chi:chitosan groups; HSPG: heparan sulfate proteoglycan; DAPI: nucleus;
Scale bar¼50 μm).
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Fig. 4. The effect of signaing transduction inhibitors was reduced in lacrimal gland explants cultured with chitosan.
(a) Western blot analyses showed suppressed phosphorylation of MAPK pathway by PD98059 in both groups. (b) Quantitative
analyses demonstrated the suppressive effect of PD98059 was greater in the control than in the chitosan groups. (c) Western
blot analyses showed suppressive phosphorylation of the Akt/PKB pathway by LY294002 in both groups. (d) Quantitative
analyses demonstrated the effect of LY294002 in the chitosan group reduced. (Cont: control group; Chi: chitosan group;
Student's test, ***po0.0001.).
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2.1. Data
The dataset of this article provides information to support the results in the article “regulating
temporospatial dynamics of morphogen for structure formation of the lacrimal gland by chitosan
biomaterials” [11]. Figs. 1–4 show the experimental setting and results to conﬁrm the regulation of
temporospatial dynamics of morphogen in lacrimal gland explant system. Table 1 shows the primer
sets used for molecular proﬁling.2.2. Chitosan facilitates lacrimal gland branching morphogenesis in a dose-dependent manner
The morphogenetic effect of chitosan was evaluated in the ex vivo culture system of embryonic
lacrimal gland explants. It is a standard model for studying branching morphogenesis of many organs
[12], and has also been used to investigate the morphogenetic effect of chitosan [13–15]. The cultured
lacrimal gland explants initiated branching morphogenesis in culture and continued through the
whole culture period. Branching was promoted when chitosan was added in the culture system
(Fig. 2a). When the concentration of chitosan increased from 0.1 to 0.3 mg/ml, it was found that
branching ratio increased correspondingly. The tendency of increased branching number correlated
with the concentration of chitosan, indicating that lacrimal gland branching morphogenesis was
promoted by chitosan in a dose-dependent manner. Between the concentration 0.3 and 0.4 mg/ml of
chitosan, no further increase of branching number was noted in the lacrimal gland explants.
Accordingly, chitosan effect was most signiﬁcant at a concentration of 0.3 mg/ml, which was then
used for the following investigation of chitosan effects (Fig. 2b)[16,17].
Y.-C. Hsiao, T.-L. Yang / Data in Brief 10 (2017) 108–1151142.3. Chitosan enhances in vivo binding afﬁnity of HGF-related molecules in cultured lacrimal gland
explants
To conﬁrm the effects of chitosan in facilitating in vivo binding of HGF-related molecules within
the cultured lacrimal gland explants, the modiﬁed LACE assay for whole-mount experiments was
performed on the cultured lacrimal gland explants in both control and chitosan groups. The ligand
and receptors of HGF-related signaling were tested for endogenous binding afﬁnity in lacrimal gland
explants. The cultured lacrimal gland explants were ﬁrst probed with c-Met in both groups (Fig. 3a).
Since the ligand-receptor binding occurred along the emerging tips of epithelia, HSPG was co-stained
to delineate the epithelial-mesenchymal boundary of cultured lacrimal gland explants. In addition,
because the interaction between c-Met and HSPG was essential to conduct HGF signaling [18], the
correlation between the localization of c-Met and HSPG provided spatial evidence of effective in vivo
binding. Analyzing the confocal imaging in serial sections, it was found that expression of c-Met
staining colocalized with that of HSPG (Fig. 3a). When both chitosan and control groups were
compared, the intensity of c-Met was greater in the chitosan group than the control, and colocalized
with HSPG. The phenomenon was obvious in the emerging tip of epithelia, where the branching was
active. Similarly, when HGF-c-Met complexes were used as the probes, staining intensity in the
chitosan group was greater than that of the control, including both probes. The staining appeared
along the epithelial-mesenchymal boundary, matching the expression pattern of HSPG. The data
showed that the in vivo afﬁnity of HGF-related molecules was promoted by chitosan at the epithelial
tip to promote branching structure of lacrimal gland explants (Fig. 3b).2.4. Chitosan regulates downstream signaling of HGF to facilitate lacrimal gland branching
morphogenesis
The speciﬁc inhibitors of the downstream pathways were applied to verify the blocking effects on
lacrimal gland structural formation. PD98059 was widely used as an inhibitors of MAPK pathway [8].
When sub-lethal doses of PD were applied, no branching promoting effects were found. Similar
phenomenon was observed when the lacrimal gland explants were treated with LY294002, the
Akt/PKB inhibitor. The results conﬁrmed the essential roles of HGF downstream signaling in chitosan
morphogenetic effects. Nonetheless, comparing the results of both groups treated by the inhibitors in
the Western blotting, the phosphorylation ratios of MAPK and Akt/PKB pathways were greater in the
chitosan than the control groups (Fig. 4). Accordingly, HGF was not the only pathway to activate the
downstream signaling of MAPK and Akt/PKB when chitosan was present.Acknowledgments
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